Multimodal lung cancer theranostics via manganese phosphate/quercetin particle

Abstract The diagnosis and treatment of non-small cell lung cancer in clinical settings face serious challenges, particularly due to the lack of integration between the two processes, which limit real-time adjustments in treatment plans based on the patient’s condition and drive-up treatment costs....

Full description

Saved in:
Bibliographic Details
Main Authors: Chong Qiu, Fei Xia, Qingchao Tu, Huan Tang, Yinan Liu, Hongda Liu, Chen Wang, HaiLu Yao, Linying Zhong, Yuanfeng Fu, Pengbo Guo, Weiqi Chen, Xinyu Zhou, Li Zou, Licheng Gan, Jiawei Yan, Yichong Hou, Junzhe Zhang, Huanhuan Pang, Yuqing Meng, Qiaoli Shi, Guang Han, Xijun Wang, Jigang Wang
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Molecular Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12943-025-02242-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825197619968737280
author Chong Qiu
Fei Xia
Qingchao Tu
Huan Tang
Yinan Liu
Hongda Liu
Chen Wang
HaiLu Yao
Linying Zhong
Yuanfeng Fu
Pengbo Guo
Weiqi Chen
Xinyu Zhou
Li Zou
Licheng Gan
Jiawei Yan
Yichong Hou
Junzhe Zhang
Huanhuan Pang
Yuqing Meng
Qiaoli Shi
Guang Han
Xijun Wang
Jigang Wang
author_facet Chong Qiu
Fei Xia
Qingchao Tu
Huan Tang
Yinan Liu
Hongda Liu
Chen Wang
HaiLu Yao
Linying Zhong
Yuanfeng Fu
Pengbo Guo
Weiqi Chen
Xinyu Zhou
Li Zou
Licheng Gan
Jiawei Yan
Yichong Hou
Junzhe Zhang
Huanhuan Pang
Yuqing Meng
Qiaoli Shi
Guang Han
Xijun Wang
Jigang Wang
author_sort Chong Qiu
collection DOAJ
description Abstract The diagnosis and treatment of non-small cell lung cancer in clinical settings face serious challenges, particularly due to the lack of integration between the two processes, which limit real-time adjustments in treatment plans based on the patient’s condition and drive-up treatment costs. Here, we present a multifunctional pH-sensitive core-shell nanoparticle containing quercetin (QCT), termed AHA@MnP/QCT NPs, designed for the simultaneous diagnosis and treatment of non-small cell lung cancer. Mechanistic studies indicated that QCT and Mn2+ exhibited excellent peroxidase-like (POD-like) activity, catalysing the conversion of endogenous hydrogen peroxide into highly toxic hydroxyl radicals through a Fenton-like reaction, depleting glutathione (GSH), promoting reactive oxygen species (ROS) generation in mitochondria and endoplasmic reticulum, and inducing ferroptosis. Additionally, Mn2+ could activate the cGAS-STING signalling pathway and promote the maturation of dendritic cells and infiltration of activated T cells, thus inducing tumor immunogenic cell death (ICD). Furthermore, it exhibited effective T2-weighted MRI enhancement for tumor imaging, making them valuable for clinical diagnosis. In vitro and in vivo experiments demonstrated that AHA@MnP/QCT NPs enabled non-invasive imaging and tumor treatment, which presented a one-stone-for-two-birds strategy for combining tumor diagnosis and treatment, with broad potential for clinical application in non-small cell lung cancer therapy. Graphical Abstract
format Article
id doaj-art-71f15366fd4745cbbed84557d3723f8f
institution Kabale University
issn 1476-4598
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj-art-71f15366fd4745cbbed84557d3723f8f2025-02-09T12:15:52ZengBMCMolecular Cancer1476-45982025-02-0124112010.1186/s12943-025-02242-9Multimodal lung cancer theranostics via manganese phosphate/quercetin particleChong Qiu0Fei Xia1Qingchao Tu2Huan Tang3Yinan Liu4Hongda Liu5Chen Wang6HaiLu Yao7Linying Zhong8Yuanfeng Fu9Pengbo Guo10Weiqi Chen11Xinyu Zhou12Li Zou13Licheng Gan14Jiawei Yan15Yichong Hou16Junzhe Zhang17Huanhuan Pang18Yuqing Meng19Qiaoli Shi20Guang Han21Xijun Wang22Jigang Wang23State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese MedicineState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese MedicineState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan UniversityState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese MedicineState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese MedicineAbstract The diagnosis and treatment of non-small cell lung cancer in clinical settings face serious challenges, particularly due to the lack of integration between the two processes, which limit real-time adjustments in treatment plans based on the patient’s condition and drive-up treatment costs. Here, we present a multifunctional pH-sensitive core-shell nanoparticle containing quercetin (QCT), termed AHA@MnP/QCT NPs, designed for the simultaneous diagnosis and treatment of non-small cell lung cancer. Mechanistic studies indicated that QCT and Mn2+ exhibited excellent peroxidase-like (POD-like) activity, catalysing the conversion of endogenous hydrogen peroxide into highly toxic hydroxyl radicals through a Fenton-like reaction, depleting glutathione (GSH), promoting reactive oxygen species (ROS) generation in mitochondria and endoplasmic reticulum, and inducing ferroptosis. Additionally, Mn2+ could activate the cGAS-STING signalling pathway and promote the maturation of dendritic cells and infiltration of activated T cells, thus inducing tumor immunogenic cell death (ICD). Furthermore, it exhibited effective T2-weighted MRI enhancement for tumor imaging, making them valuable for clinical diagnosis. In vitro and in vivo experiments demonstrated that AHA@MnP/QCT NPs enabled non-invasive imaging and tumor treatment, which presented a one-stone-for-two-birds strategy for combining tumor diagnosis and treatment, with broad potential for clinical application in non-small cell lung cancer therapy. Graphical Abstracthttps://doi.org/10.1186/s12943-025-02242-9Integrated diagnosis and treatmentAntitumor therapyMagnetic resonance imagingQuercetinManganese phosphate
spellingShingle Chong Qiu
Fei Xia
Qingchao Tu
Huan Tang
Yinan Liu
Hongda Liu
Chen Wang
HaiLu Yao
Linying Zhong
Yuanfeng Fu
Pengbo Guo
Weiqi Chen
Xinyu Zhou
Li Zou
Licheng Gan
Jiawei Yan
Yichong Hou
Junzhe Zhang
Huanhuan Pang
Yuqing Meng
Qiaoli Shi
Guang Han
Xijun Wang
Jigang Wang
Multimodal lung cancer theranostics via manganese phosphate/quercetin particle
Molecular Cancer
Integrated diagnosis and treatment
Antitumor therapy
Magnetic resonance imaging
Quercetin
Manganese phosphate
title Multimodal lung cancer theranostics via manganese phosphate/quercetin particle
title_full Multimodal lung cancer theranostics via manganese phosphate/quercetin particle
title_fullStr Multimodal lung cancer theranostics via manganese phosphate/quercetin particle
title_full_unstemmed Multimodal lung cancer theranostics via manganese phosphate/quercetin particle
title_short Multimodal lung cancer theranostics via manganese phosphate/quercetin particle
title_sort multimodal lung cancer theranostics via manganese phosphate quercetin particle
topic Integrated diagnosis and treatment
Antitumor therapy
Magnetic resonance imaging
Quercetin
Manganese phosphate
url https://doi.org/10.1186/s12943-025-02242-9
work_keys_str_mv AT chongqiu multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT feixia multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT qingchaotu multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT huantang multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT yinanliu multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT hongdaliu multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT chenwang multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT hailuyao multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT linyingzhong multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT yuanfengfu multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT pengboguo multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT weiqichen multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT xinyuzhou multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT lizou multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT lichenggan multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT jiaweiyan multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT yichonghou multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT junzhezhang multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT huanhuanpang multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT yuqingmeng multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT qiaolishi multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT guanghan multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT xijunwang multimodallungcancertheranosticsviamanganesephosphatequercetinparticle
AT jigangwang multimodallungcancertheranosticsviamanganesephosphatequercetinparticle